Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Ferronha

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 15, 2013
LMO4 is an essential cofactor in the Snail2-mediated epithelial-to-mesenchymal transition of neuroblastoma and neural crest cellsTiago Ferronha, M Angeles Rabadán, Estel Gil-Guiñon, et al.
Development (Cambridge, England)|December 14, 2011
Canonical BMP7 activity is required for the generation of discrete neuronal populations in the dorsal spinal cordGwenvael Le Dréau, Lidia Garcia-Campmany, M Angeles Rabadán, et al.
Hepatology (Baltimore, Md.)|December 19, 2018
Tuning T-Cell Receptor Affinity to Optimize Clinical Risk-Benefit When Targeting Alpha-Fetoprotein-Positive Liver CancerRoslin Y Docta, Tiago Ferronha, Joseph P Sanderson, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 15, 2013
LMO4 is an essential cofactor in the Snail2-mediated epithelial-to-mesenchymal transition of neuroblastoma and neural crest cellsTiago Ferronha, M Angeles Rabadán, Estel Gil-Guiñon, et al.
Development (Cambridge, England)|December 14, 2011
Canonical BMP7 activity is required for the generation of discrete neuronal populations in the dorsal spinal cordGwenvael Le Dréau, Lidia Garcia-Campmany, M Angeles Rabadán, et al.
Hepatology (Baltimore, Md.)|December 19, 2018
Tuning T-Cell Receptor Affinity to Optimize Clinical Risk-Benefit When Targeting Alpha-Fetoprotein-Positive Liver CancerRoslin Y Docta, Tiago Ferronha, Joseph P Sanderson, et al.
Pageof 1